We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
-3.56%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$39.9B
AUM Growth
-$3.99B
(-9.1%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-2.97%
Top 10 Holdings %
Top 10 Hldgs %
37.22%
Holding
1,874
New
146
Increased
562
Reduced
366
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$543M |
| 2 |
NVIDIA
NVDA
|
+$373M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$178M |
| 4 |
AbbVie
ABBV
|
+$149M |
| 5 |
Microsoft
MSFT
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$598M |
| 2 |
Netflix
NFLX
|
+$259M |
| 3 |
Johnson & Johnson
JNJ
|
+$239M |
| 4 |
Amazon
AMZN
|
+$217M |
| 5 |
Visa
V
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.27% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.52% |
| 4 | Communication Services | 10.2% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Stepan Co
SCL
$1.3B
| $40K | ﹤0.01% |
797
| – | – |
|
1727
Biohaven
BHVN
$2.17B
| $39K | ﹤0.01% |
4,560
| – | – |
|
1728
Enovis
ENOV
$1.48B
| $39K | ﹤0.01% |
1,708
| – | – |
|
1729
Kodiak Sciences
KOD
$2.59B
| $39K | ﹤0.01% |
+1,014
| New | +$26.2K |
|
1730
Novavax
NVAX
$1.28B
| $39K | ﹤0.01% |
4,746
+1,229
| +35% | +$11.1K |
|
1731
QuidelOrtho
QDEL
$1.12B
| $39K | ﹤0.01% |
2,349
| – | – |
|
1732
RLJ Lodging Trust
RLJ
$1.82B
| $39K | ﹤0.01% |
5,258
| – | – |
|
1733
Sally Beauty Holdings
SBH
$1.37B
| $39K | ﹤0.01% |
+2,789
| New | +$42.5K |
|
1734
Tennant Co
TNC
$1.46B
| $39K | ﹤0.01% |
590
| – | – |
|
1735
Tandem Diabetes Care
TNDM
$1.11B
| $39K | ﹤0.01% |
2,011
| – | – |
|
|
BELFB
1736
Bel Fuse Inc Class B
BELFB
$4.08B
| $38K | ﹤0.01% |
+192
| New | +$40.1K |
|
1737
Concentrix
CNXC
$1.35B
| $38K | ﹤0.01% |
1,392
| – | – |
|
1738
Enliven Therapeutics
ELVN
$3.79B
| $38K | ﹤0.01% |
+958
| New | +$26.5K |
|
1739
Flywire
FLYW
$2B
| $38K | ﹤0.01% |
+3,288
| New | +$41.4K |
|
1740
ICF International
ICFI
$1.39B
| $38K | ﹤0.01% |
588
| – | – |
|
1741
Dorian LPG
LPG
$1.93B
| $38K | ﹤0.01% |
+1,120
| New | +$35.5K |
|
1742
NextNav
NN
$1.79B
| $38K | ﹤0.01% |
+2,392
| New | +$38.7K |
|
1743
Gibraltar Industries
ROCK
$1.31B
| $38K | ﹤0.01% |
961
| – | – |
|
1744
Recursion Pharmaceuticals
RXRX
$1.59B
| $38K | ﹤0.01% |
12,307
| – | – |
|
|
FLY
1745
Firefly Aerospace
FLY
$3.41B
| $38K | ﹤0.01% |
+1,318
| New | +$32.1K |
|
1746
Coty
COTY
$2.22B
| $37K | ﹤0.01% |
18,301
| – | – |
|
1747
NewAmsterdam Pharma
NAMS
$3.64B
| $37K | ﹤0.01% |
+1,171
| New | +$38.1K |
|
1748
Nuvation Bio
NUVB
$2.27B
| $37K | ﹤0.01% |
+8,699
| New | +$48.5K |
|
1749
NovoCure
NVCR
$2.34B
| $37K | ﹤0.01% |
3,369
| – | – |
|
1750
Alaska Air
ALK
$4.88B
| $36K | ﹤0.01% |
970
| – | – |
|
Similar funds
HF
KBC Group's Q1 2026 Portfolio in Review
As of Q1 2026, KBC Group held 1,874 positions worth $39.9B, down 9.1% from $43.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
KBC Group's Q1 2026 filing shows 146 new, 562 increased, 366 reduced and 20 closed positions. Its largest new stake was AbbVie: 669,647 shares worth $146M. The largest sale was Alphabet (Google) Class C, an estimated $598M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- KBC Group's largest Q1 2026 buy was AbbVie: 669,647 shares worth $146M.
- KBC Group added most to Apple in Q1 2026, an estimated $543M increase.
- KBC Group's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $598M.
- KBC Group fully exited CyberArk in Q1 2026, selling an estimated $6.81M.
- KBC Group's ten largest holdings make up 37% of its $39.9B portfolio in Q1 2026.
- KBC Group opened 146 new positions and closed 20 in Q1 2026.
- KBC Group's portfolio value fell 9.1% quarter-over-quarter to $39.9B.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.